◀ Back to LOX

BCL2 — LOX

Text-mined interactions from Literome

Gáti et al., Prostaglandins Leukot Essent Fatty Acids 2007 (Muscular Dystrophy, Duchenne) : Inhibition of PLA2 and LOX with prednisolone and nordihydroguaiaretic acid ( NDGA ) caused a semi-quantitative increase of utrophin and Bcl-2- , and a dose dependent, quantitative increase of desmin expression, an effect that was augmented by hypo-osmotic treatment
Cristofanon et al., Biochem Pharmacol 2008 : Two lipoxygenase (LOX) inhibitors ( CAPE or AA861 ) prevent ROS increase and, accordingly, also prevent Bcl-2 up-regulation